Wegovy

FDA-approved GLP-1 medications and their generic active ingredients.

Definition

Once-weekly injectable semaglutide approved by the FDA in 2021 for chronic weight management. Same active ingredient as Ozempic but at higher doses (0.25 to 2.4 mg weekly).

Wegovy in our brand-comparison piece →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in Drugs and brands

Ozempic
Rybelsus
Saxenda
Zepbound
Mounjaro
Foundayo
Semaglutide
Tirzepatide
Orforglipron
Retatrutide
CagriSema
Cagrilintide
Survodutide
MariTide (Maridebart Cafraglutide)
Ecnoglutide

Looking for more depth?

Wegovy in our brand-comparison piece
Browse the full GLP-1 glossary (51 terms across 8 categories)
Research articles — primary-source deep dives
Tools and calculators
Compare GLP-1 telehealth providers